(Q45169384)

English

Glucagon-like peptide-1 analogue, liraglutide, improves liver fibrosis markers in obese women with polycystic ovary syndrome and nonalcoholic fatty liver disease.

scientific article published on 12 December 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24256515%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Glucagon-like peptide-1 analogue, liraglutide, improves liver fibrosis markers in obese women with polycystic ovary syndrome and nonalcoholic fatty liver disease (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24256515%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

0 references

polycystic ovary syndrome

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

metabolic dysfunction–associated steatotic liver disease

1 reference

based on heuristic

inferred from title

polycystic ovary

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24256515%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Stephen L. Atkin

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24256515%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

author name string

H Kahal

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24256515%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

G Abouda

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24256515%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

A S Rigby

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24256515%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

E S Kilpatrick

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24256515%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

publication date

12 December 2013

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24256515%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Clinical Endocrinology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24256515%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

81

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24256515%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24256515%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

523-528

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24256515%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12369

21 January 2018

Nonalcoholic steatohepatitis and nonalcoholic Fatty liver disease in young women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12369

21 January 2018

Obesity-associated liver disease

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12369

21 January 2018

Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12369

21 January 2018

Obesity and hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12369

21 January 2018

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12369

21 January 2018

Clinical Review: Nonalcoholic fatty liver disease: a novel cardiometabolic risk factor for type 2 diabetes and its complications.

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12369

21 January 2018

Therapeutic effects of restricted diet and exercise in obese patients with fatty liver.

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12369

21 January 2018

Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12369

21 January 2018

Validation of terminal peptide of procollagen III for the detection and assessment of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12369

21 January 2018

Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12369

21 January 2018

Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12369

21 January 2018

Glp-1 analog, liraglutide, ameliorates hepatic steatosis and cardiac hypertrophy in C57BL/6J mice fed a Western diet

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12369

21 January 2018

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12369

21 January 2018

Polycystic ovary syndrome has no independent effect on vascular, inflammatory or thrombotic markers when matched for obesity

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12369

21 January 2018

Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease.

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12369

21 January 2018

Post hoc power analysis: an idea whose time has passed?

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12369

21 January 2018

Imputation of missing longitudinal data: a comparison of methods

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12369

21 January 2018

Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review.

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12369

21 January 2018

Improved glycaemia correlates with liver fat reduction in obese, type 2 diabetes, patients given glucagon-like peptide-1 (GLP-1) receptor agonists

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12369

21 January 2018

The effects of 8 months of metformin on circulating GGT and ALT levels in obese women with polycystic ovarian syndrome

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12369

21 January 2018

GLP-1 analogs reduce hepatocyte steatosis and improve survival by enhancing the unfolded protein response and promoting macroautophagy

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12369

21 January 2018

Glucagon-like peptide-1 receptor is present on human hepatocytes and has a direct role in decreasing hepatic steatosis in vitro by modulating elements of the insulin signaling pathway

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12369

21 January 2018

Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12369

21 January 2018

Exendin-4 improves steatohepatitis by increasing Sirt1 expression in high-fat diet-induced obese C57BL/6J mice

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12369

21 January 2018

GLP-1 Receptor Agonist and Non-Alcoholic Fatty Liver Disease

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12369

21 January 2018

Identifiers

10.1111/CEN.12369

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24256515%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24256515%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45169384&oldid=1588402025"